Prescribed Drug Registry in Sweden
The interest in using real-world data (RWD) to inform decision-making has significantly increased in recent years. Sweden has a long tradition of using RWD, frequently combining data from different registers.
- Learn more about the drug-registry from this blog.
Data sources and variables (Mattias Kyhlstedt)
An analysis that can provide a true signal of effect based on real-world data sources requires rich, high-quality data sources with opportunities for record-linkage. To frame the discussion, an overview of different categories of data sources and types of variables will be presented.
Experience of RWD research using the Swedish prescribed drug registry (Prof Björn Wettermark)
With decades of experience in research with RWD, Prof Wettermark will share his experience on how to carry out RWE research that provides a true signal of effect:
- What data is needed?
- Required competence and clinical understanding.
- High-level overview of the experience from the Swedish Prescribed Drug registry and other registers
Questions and answers
Björn Wettermark, M.Sc.Pharm, PhD is professor of pharmacoepidemiology at Uppsala university, Sweden and visiting professor at Vilnius university, Lithuania. His research focus mainly on drug utilization as a tool in health policy including prescribing quality indicators, international comparisons of drug utilization, evaluation of prescribing doctors´ adherence to guidelines and patient adherence to treatment as well as intervention studies to promote rational use of drugs. He has previously had various managerial positions in the health region of Stockholm as well as other commitments including membership in national and regional strategic groups on medicine management, scientific advisor to the Swedish Medical Products Agency as well as chair of the European Drug Utilization Research group (EuroDURG), the European chapter of the International Society for Pharmacoepidemiology. He is currently board member of the Swedish Society for Epidemiology, the Swedish Pharmaceutical society and EuroDURG as well as senior communication manager in the COST Action “European Network to Advance Best practices & technoLogy on medication adherencE” (ENABLE).
Registration: https://us06web.zoom.us/webinar/register/WN_CoYT0ETPScy0T0D7-ri-lA